Investing Early — Has the Bar Moved in Early-Stage VC, and How Should CEOs React? | LSI USA '25

Early-stage VC experts from Heinz Ventures, Opal Ventures, Edge Medical Ventures, and Good Growth Capital discuss how investment criteria have evolved and share strategic insights for CEOs navigating this shifting landscape.

LSI Asia ‘25 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

June 10th - 13th, 2025The Ritz-Carlton, Millenia Singapore Register arrow